137 related articles for article (PubMed ID: 3331217)
1. Mechanism of myelofibrosis in chronic myeloproliferative disorders.
Yonekura S
Tokai J Exp Clin Med; 1987 Sep; 12(3):141-5. PubMed ID: 3331217
[No Abstract] [Full Text] [Related]
2. [Role of PDGF on myeloproliferative disorders].
Kimura A; Katoh O; Kuramoto A
Rinsho Ketsueki; 1988 Jul; 29(7):989-93. PubMed ID: 3184485
[No Abstract] [Full Text] [Related]
3. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
4. [Mechanism of myelofibrosis in chronic myeloproliferative disorders].
Nagao T; Yonekura S
Rinsho Ketsueki; 1988 Jul; 29(7):983-8. PubMed ID: 2846914
[No Abstract] [Full Text] [Related]
5. Myelofibrosis in myeloproliferative disorders.
Srinivasan U; Talvalkar GV; Advani SH
Indian J Cancer; 1978 Sep; 15(3):37-43. PubMed ID: 294411
[No Abstract] [Full Text] [Related]
6. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease.
Gilbert HS
Prog Clin Biol Res; 1984; 154():3-17. PubMed ID: 6382299
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
Zankovich R; Thiele J; Fischer R; Diehl V
Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
[No Abstract] [Full Text] [Related]
9. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
Duhamel G; Stachowiak J
Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic myelofibrosis. Clinical aspects and studies on extracellular matrix metabolism.
Hasselbalch HC
Dan Med Bull; 1993 Mar; 40(1):39-55. PubMed ID: 8472598
[No Abstract] [Full Text] [Related]
11. Myelofibrosis in the myeloproliferative disorders.
Ellis JT; Peterson P
Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
[TBL] [Abstract][Full Text] [Related]
12. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
13. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
Thiele J; Kvasnicka HM; Vardiman J
Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
[TBL] [Abstract][Full Text] [Related]
14. Properties of myelofibrosis-derived fibroblasts.
Castro-Malaspina H; Jhanwar SC
Prog Clin Biol Res; 1984; 154():307-22. PubMed ID: 6382300
[TBL] [Abstract][Full Text] [Related]
15. Hematopathologic findings in the myeloproliferative disorders.
Dickstein JI; Vardiman JW
Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
[TBL] [Abstract][Full Text] [Related]
16. Myelofibrosis: a role for platelet derived growth factor (PDGF)?
Romano M; Poggi A
Haematologica; 1986; 71(5):359-61. PubMed ID: 3096830
[No Abstract] [Full Text] [Related]
17. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor receptor β (PDGFRβ) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia.
Méhes G; Tzankov A; Hebeda K; Anagnostopoulos I; Krenács L; Bedekovics J
Histopathology; 2015 Nov; 67(5):617-24. PubMed ID: 25825163
[TBL] [Abstract][Full Text] [Related]
19. [Atypical myeloproliferative disorders: a study on 3 cases showing pancytopenia, marrow fibrosis and the absence of splenomegaly].
Yoshida Y; Yamagishi M; Fukuhara S; Sawada H; Ohkuma M; Uchino H; Nakamura T
Rinsho Ketsueki; 1984 Mar; 25(3):383-92. PubMed ID: 6471435
[No Abstract] [Full Text] [Related]
20. [So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. I. Initial clinical and histologic findings in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages].
Zankovich R; Thiele J; Mödder B; Steinberg T; Simon KG; Fischer R; Diehl V
Med Klin (Munich); 1988 Oct; 83(19):617-28. PubMed ID: 3185420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
